Xtant Medical Holdings, Inc. (XTNT) Fair Value 2026

XTNT · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.4 /10

32 fundamental signals · 8 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-08-28, Xtant Medical Holdings, Inc. (XTNT) trades at $0.38, versus a $0.79 median fair value across its 8 active models — 106.5% above the current price. QOC: 8.4/10. Value Trap Risk: 13/100 (SAFE). 8/13 models active.

Key Facts

Ticker
XTNT
Price
$0.38
Quality Score
8.4/10
Value Trap Risk
13/100
Models Active
8/13
Last Updated
Strength: First Chicago suggests +431.9% upside with 59% confidence
Risk: Limited model coverage (8/13) may reduce confidence

Is Xtant Medical Holdings, Inc. (XTNT) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, Xtant Medical Holdings, Inc. (XTNT) appears undervalued as of : the median of 8 independent fair value estimates is $0.79, 106.5% above the current price of $0.38. Estimates range from $0.20 to $2.04. XTNT scores 8.4/10 on fundamental quality and 13/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. XTNT’s +106.5% gap is wider than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Xtant Medical Holdings, Inc. Stock in 2026? →

What Fair Value Does Each Model Give XTNT?

8 Intrinsic Value Models vs. Current Price ($0.38)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $0.82 +114.0%
Scenario · High Conviction
 $2.04 +431.9%
Asset-Based · High Conviction
 $0.20 -47.9%
Intrinsic · Medium Conviction
 $0.36 -7.2%
Unlock the Full Matrix

Access 4 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is XTNT's Fair Value Range?

Spread across 8 independent models · $0.20 to $2.04

CirclFi's 8 active models place Xtant Medical Holdings, Inc. (XTNT) between $0.20 and $2.04 per share, a spread of 232% of the median. The median of that range — $0.79 — is the fair value CirclFi publishes for XTNT, against a current price of $0.38.

Low · Dynamic NAVHigh · First Chicago
$0.20median $0.79$2.04
Where the range comes from
Most bearish modelDynamic NAV$0.20
Most bullish modelFirst Chicago$2.04
Model agreement6 bullish · 2 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for XTNT. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on XTNT, not a CirclFi price target. How each model works →

What Is Xtant Medical Holdings, Inc. (XTNT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Xtant Medical Holdings, Inc.'s intrinsic value is estimated at a median fair value of $0.79. At a current market price of $0.38, 6 of 8 active valuation models identify upside potential, projecting a median implied return of +106.5%. Notably, First Chicago sees the most upside at +431.9% (fair value: $2.04), while Dynamic NAV is the most conservative at -47.9% ($0.20). The spread between these extremes — +479.8% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About XTNT?

8 of 13 models are currently active for XTNT. Of these, 6 models suggest upside while 2 models suggest overvaluation. Taken together, their median fair value for XTNT is $0.79 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does XTNT Rank in Medical Devices?

Among 159 Medical Devices stocks, XTNT ranks #20 by Quality of Company score. CirclFi's QOC score of 8.4/10 evaluates 32 fundamental signals. A score of 8.4 places XTNT in the top tier.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to healthcare company businesses. For Xtant Medical Holdings, Inc., metrics like revenue per drug provide important context that general-purpose valuation models may underweight.

Is XTNT a Value Trap?

CirclFi's Value Trap algorithm assigns XTNT a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Xtant Medical Holdings, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Xtant Medical Holdings, Inc. scores 8.4 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +479.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every XTNT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across XTNT's 8 active models, average confidence is 41%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Xtant Medical Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

CNMDCONMED CorporationQOC 8.5ZBHZimmer Biomet Holdings, Inc.QOC 8.4INMDInMode Ltd.QOC 8.5HAEHaemonetics CorporationQOC 8.3SNNSmith & Nephew plcQOC 8.6USAQQHSLab, Inc.QOC 8.3PROFProfound Medical Corp.QOC 6.8ADMTADM Tronics Unlimited, Inc.QOC 5.8BJDXBluejay Diagnostics, Inc.QOC 4.4IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: CNMD · ZBH · INMD · HAE · SNN · USAQ · PROF · ADMT · BJDX · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to XTNT?

7 companies across all industries closest to XTNT’s Quality of Company score of 8.4/10.

LWAYLifeway Foods, Inc.QOC 8.4MZTIThe Marzetti CompanyQOC 8.4SYBTStock Yards Bancorp, Inc.QOC 8.4BCRXBioCryst Pharmaceuticals, Inc.QOC 8.4AMALAmalgamated Financial Corp.QOC 8.4HBCPHome Bancorp, Inc.QOC 8.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LWAY · MZTI · SYBT · BCRX · AMAL · HBCP · NVDA

Where Does XTNT Sit in CirclFi's Medical Devices Rankings?

XTNT is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Xtant Medical Holdings, Inc.’s Valuation?

What is Xtant Medical Holdings, Inc.'s intrinsic value in 2026?

CirclFi puts Xtant Medical Holdings, Inc. (XTNT)'s intrinsic value at $0.79 — the median of 8 independent model estimates as of 2026-08-28, ranging from $0.20 to $2.04. The Quality of Company score is 8.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is XTNT overvalued or undervalued right now?

At $0.38, 6 of 8 active models suggest XTNT may be undervalued, while 2 indicate potential overvaluation. The median of all 8 fair value estimates is $0.79, 106.5% above the current price of $0.38 — a consensus view that XTNT is undervalued. The assessment depends on which methodology best fits Xtant Medical Holdings, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 8.4 mean for XTNT?

Xtant Medical Holdings, Inc.'s QOC of 8.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on XTNT?

CirclFi analyzes XTNT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on XTNT?

Of the 8 models currently active on XTNT, First Chicago is the most bullish at $2.04 per share, and Dynamic NAV is the most bearish at $0.20. CirclFi's published fair value for XTNT is the median of that range, $0.79, not either extreme. The gap between the two ends equals 232% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is XTNT a value trap in 2026?

Xtant Medical Holdings, Inc.'s Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 8-model valuation engine, Xtant Medical Holdings, Inc. (XTNT) has a median fair value of $0.79 — 106.5% above the current price of $0.38 — as of 2026-08-28.” Source: circlfi.com/stock/XTNT/ · Methodology
Primary sources for this XTNT valuation
  • Financial statements: Xtant Medical Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001453593) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for XTNT as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on XTNT.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for XTNT Unlock All 8 — $39/mo